Tavexia Lifecare Limited has adjourned its board meeting originally scheduled for September 4, 2026, to September 7, 2026.

The company, formerly known as Sattva Sukun Lifecare Limited, cited unavoidable circumstances for the postponement. The meeting will now convene at its registered office in Mumbai on the new date.

Governance and Compliance

The agenda for the rescheduled meeting remains unchanged from the original intimation. The board will consider several critical compliance matters under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key items on the agenda include:

• Approval of the Board Report, Corporate Governance Report, and Management Discussion and Analysis for FY26.
• Consideration of the Secretarial Auditor Report for FY2025-26.
• Proposal for the re-appointment of Mrs. Khushboo Vasudev as an Independent Director for a second term of five years, subject to shareholder approval.
• Setting specific limits for material related-party transactions under Section 188 of the Companies Act, 2013.

AGM Logistics

The meeting will also determine the logistical details for the upcoming AGM. This includes fixing the date, time, and venue for the event, as well as determining the closure dates for the Register of Members and Transfer Books to facilitate e-voting.

The board will appoint a scrutinizer to oversee the e-voting and poll processes. Additionally, the Managing Director or Company Secretary will be authorized to issue the AGM notice and manage the conduct of the meeting.

Sattva Sukun Lifecare reported a standalone net loss of ₹23.38 lakh for the first quarter of FY27, marking a significant turnaround from the net profit of ₹65.14 lakh recorded in Q1FY26. The deterioration in profitability was driven by an 80.7% year-on-year decline in total income from operations to ₹23.41 lakh, coupled with a rise in total expenses to ₹60.77 lakh from ₹52.43 lakh in the previous year’s corresponding period.

The company submitted its unaudited financial results (standalone and consolidated) to the Bombay Stock Exchange on August 5, 2026, in compliance with Regulation 47(l)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were published in Mumbai Lakshadweep and Active Times newspapers. Mit Tarunkumar Brahmbhatt, Managing Director, signed the financial statement dated August 4, 2026.

Financial Performance

The sharp contraction in revenue highlights operational challenges during the quarter. While income fell drastically, expenses increased by approximately 15.9% compared to Q1FY25, leading to a widening pre-tax loss.

On a consolidated basis, the group reported a net loss of ₹16.01 lakh after tax, compared to a profit of ₹65.14 lakh in Q1FY26. Consolidated income from operations stood at ₹76.07 lakh, a decline from ₹121.61 lakh in the prior year period. Consolidated expenses rose to ₹107.11 lakh from ₹52.43 lakh.

Quarter-on-Quarter Movement

Compared to the preceding quarter (Q4FY26), the standalone net loss narrowed to ₹23.38 lakh from ₹56.97 lakh. However, this improvement coincided with a further drop in revenue, which fell to ₹23.41 lakh from ₹31.41 lakh in Q4FY26. Expenses also decreased significantly to ₹60.77 lakh from ₹106.30 lakh in the previous quarter.

What the Numbers Show

The divergence between revenue collapse and expense inflation is the critical concern for investors. While income plummeted by over 80% year-on-year, operating expenses did not scale down proportionally, rising nearly 16%. This suggests fixed cost rigidity or specific one-time expenditures that eroded margins entirely. The basic earnings per share turned negative at -₹0.01, reflecting the impact on shareholder value. With paid-up equity capital remaining stable at ₹3,836.01 lakh, the dilution effect is limited, but the profitability reversal signals a need for operational restructuring or revenue recovery strategies in subsequent quarters.